Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...

A/S, a global healthcare company specializing in diabetes care and other chronic conditions, has been at the forefront of the rapidly expanding GLP-1 market. With a market capitalization of $376.79 ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

For five years now, a bipartisan group of Illinois lawmakers have wanted to establish a Prescription Drug Affordability Board. But this year’s effort may hit the same wall as before.

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

PharmEasy is redefining healthcare delivery in India. In the inaugural episode of the Masters of CX - Season 3, CEO Siddharth Shah reveals how the company leverages technology to overcome geographical ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

The US Food and Drug Administration on Tuesday approved Ozempic for adults with type 2 diabetes and chronic kidney disease (CKD). The drug is now indicated specifically to treat kidney failure, ...

A thorough examination of modern drugs that target particular receptors and metabolic pathways for glucose and fat metabolism is presented. Recent research has revealed innovative targets and ...